title: The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
abstract: Initially discovered as an estrogen-responsive gene in breast cancer cell lines, anterior gradient 2 (AGR2) is a developmentally regulated gene belonging to the protein disulfide isomerase (PDI) gene family. Developmentally, AGR2 is expressed in the mammary gland in an estrogen-dependent manner, and AGR2 knockout and overexpression mouse models indicate that the gene promotes lobuloalveolar development by stimulating cell proliferation. Although AGR2 overexpression alone seems insufficient for breast tumorigenesis in mice, several lines of investigations suggest that AGR2 promotes breast tumorigenesis. Overexpression of AGR2 in several breast cancer cell lines increases cell survival in clonogenic assays and cell proliferation, whereas AGR2 loss of function leads to decreased cell cycle progression and cell death. In addition, AGR2 was shown to promote metastasis of breast epithelial cells in an in vivo metastasis assay. As a PDI, AGR2 is thought to be involved in the unfolded protein response that alleviates endoplasmic reticulum stress. Since cancer has to overcome proteotoxic stress due to excess protein production, AGR2 may be one of many pro-survival factors recruited to assist in protein folding or degradation or both. When AGR2 is secreted, it plays a role in cellular adhesion and dissemination of metastatic tumor cells. In breast cancer, AGR2 expression is associated with estrogen receptor (ER)-positive tumors; its overexpression is a predictor of poor prognosis. The AGR2 gene is directly targeted by ER-alpha, which is preferentially bound in tumors with poor outcome. Whereas aromatase inhibitor therapy decreases AGR2 expression, tamoxifen acts as an agonist of AGR2 expression in ER-positive tumors, perhaps contributing to tamoxifen resistance. AGR2 is also overexpressed in a subset of ER-negative tumors. Furthermore, AGR2 expression is associated with the dissemination of metastatic breast cancer cells and can be used as a marker to identify circulating tumor cells and metastatic cells in sentinel lymph nodes. In conclusion, AGR2 is a promising drug target in breast cancer and may serve as a useful prognostic indicator as well as a marker of breast cancer metastasis.
authors: Michael L
authors: ML
authors: Salmans
authors: Fang
authors: F
authors: Zhao
authors: Bogi
authors: B
authors: Andersen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D051379:Mice; D058990:Molecular Targeted Therapy; D009088:Mucoproteins; D015513:Oncogene Proteins; D011506:Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: C502296:AGR2 protein, human; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D009088:Mucoproteins; D015513:Oncogene Proteins; D011506:Proteins
references: Mol Cell Biochem. 2007 Dec;306(1-2):255-60
references: 17694278
references: Cancer Res. 2005 Jun 15;65(12):4993-7
references: 15958538
references: Clin Cancer Res. 2006 Mar 15;12(6):1728-34
references: 16551856
references: Biochem Biophys Res Commun. 1998 Oct 9;251(1):111-6
references: 9790916
references: Mol Cell Proteomics. 2004 Jun;3(6):534-47
references: 14967811
references: Dev Biol. 2010 Feb 15;338(2):270-9
references: 20025862
references: Cell. 2008 Mar 21;132(6):945-57
references: 18358808
references: BMC Cancer. 2010 Dec 13;10:680
references: 21144054
references: J Proteome Res. 2011 Oct 7;10(10):4567-78
references: 21936522
references: Nat Rev Cancer. 2005 Oct;5(10):761-72
references: 16175177
references: J Mol Biol. 2010 Dec 3;404(3):418-38
references: 20888340
references: Nat Rev Cancer. 2009 Dec;9(12):874-85
references: 19935676
references: J Biol Chem. 2003 Feb 21;278(8):6482-9
references: 12477722
references: Nat Cell Biol. 2006 Jun;8(6):631-9
references: 16699503
references: Nat Rev Mol Cell Biol. 2002 Nov;3(11):836-47
references: 12415301
references: Breast Cancer. 2012 Apr;19(2):118-24
references: 22139728
references: Mech Dev. 1998 Mar;72(1-2):115-30
references: 9533957
references: Mol Phylogenet Evol. 2005 Sep;36(3):734-40
references: 15935701
references: Endocr Relat Cancer. 2006 Jun;13(2):617-28
references: 16728587
references: Cancer Detect Prev. 2008;32(3):236-50
references: 18801625
references: Oncogene. 2013 Aug 15;32(33):3867-76
references: 22945649
references: Mol Cell. 2006 Jan 20;21(2):295-305
references: 16427018
references: Genes Chromosomes Cancer. 2005 Jul;43(3):249-59
references: 15834940
references: Nature. 2012 Jan 04;481(7381):389-93
references: 22217937
references: EMBO J. 2009 May 20;28(10):1418-28
references: 19339991
references: Breast Cancer Res. 2011 Aug 04;13(4):R75
references: 21816090
references: Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):31-6
references: 21768879
references: Oncogene. 2010 Aug 26;29(34):4838-47
references: 20531310
references: Breast Cancer Res. 2007;9(3):R37
references: 17555561
references: Oncogene. 2012 Mar 1;31(9):1196-206
references: 21785460
references: Nature. 2000 Aug 17;406(6797):747-52
references: 10963602
references: J Biol Chem. 2011 Dec 30;286(52):44855-68
references: 22025610
references: Breast Cancer Res. 2010;12(5):R68
references: 20813035
references: Cancer Res. 2008 Oct 1;68(19):7811-8
references: 18829536
references: Cancer Res. 2010 Jan 1;70(1):240-8
references: 20048076
references: Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):6950-5
references: 19359471
references: Cell. 2009 Mar 6;136(5):823-37
references: 19269363
references: Exp Mol Med. 2011 Feb 28;43(2):91-100
references: 21200134
references: Am J Pathol. 2009 Nov;175(5):1848-57
references: 19834055
references: Exp Mol Med. 2012 Jan 31;44(1):60-7
references: 22089087
references: Am J Respir Cell Mol Biol. 2012 Aug;47(2):178-85
references: 22403803
references: Antioxid Redox Signal. 2009 Oct;11(10):2553-61
references: 19388826
references: Genetics. 2006 Sep;174(1):241-51
references: 16816423
references: Urology. 2012 Jan;79(1):240.e9-15
references: 22055693
references: Breast Cancer Res. 2010;12(3):R32
references: 20525379
references: J Immunol Methods. 2012 Apr 30;378(1-2):20-32
references: 22361111
references: FEBS J. 2013 Mar;280(5):1249-66
references: 23294566
references: Cancer Res. 2008 Jan 15;68(2):492-7
references: 18199544
references: Dev Biol. 2012 Sep 15;369(2):249-60
references: 22819674
references: J Biol Chem. 2009 Jul 3;284(27):18115-28
references: 19433865
references: Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14536-41
references: 19706540
references: N Engl J Med. 2012 Aug 2;367(5):435-44
references: 22853014
references: Oncol Rep. 2011 Mar;25(3):717-27
references: 21206979
references: J Comp Pathol. 2012 Feb-Apr;146(2-3):143-51
references: 21783201
references: Toxicol Sci. 2010 Jun;115(2):501-12
references: 20299546
references: Cancer Res. 2005 May 1;65(9):3796-805
references: 15867376
references: Nucleic Acids Res. 1998 Feb 15;26(4):1116-23
references: 9461476
references: Br J Cancer. 2006 Apr 10;94(7):1057-65
references: 16598187
references: Cancer Res. 2011 Nov 15;71(22):7091-102
references: 21948970
references: Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11799-804
references: 16087886
references: Nature. 2009 Nov 5;462(7269):58-64
references: 19890323
references: Nat Cell Biol. 2006 Oct;8(10):1053-63
references: 16964246
references: Antioxid Redox Signal. 2011 Aug 1;15(3):621-33
references: 21299467
references: Cancer Res. 2010 Nov 1;70(21):8446-56
references: 20847343
references: Antioxid Redox Signal. 2012 Apr 15;16(8):781-9
references: 22142258
references: J Biol Chem. 2011 May 20;286(20):18301-10
references: 21454516
references: Clin Exp Metastasis. 2007;24(6):411-22
references: 17593529
references: Br J Cancer. 2003 Feb 24;88(4):579-85
references: 12592373
references: N Engl J Med. 2002 Dec 19;347(25):1999-2009
references: 12490681
references: Biochim Biophys Acta. 2011 Apr;1815(2):224-40
references: 21277939
references: Cytogenet Cell Genet. 2000;89(3-4):141-2
references: 10965104
references: Oncogene. 2003 Oct 20;22(47):7316-39
references: 14576841